The Medical Countermeasures Coalition (MC2) is a brand dedicated to the development and sustainment of medical countermeasures, making it a top priority in the face of emerging public health threats. Their mission is to support sound public policy, strong public-private partnerships, and facilitate research, development, manufacturing, access, and distribution of medical countermeasures. Medical countermeasures are medicines and medical supplies designed to diagnose, prevent, or treat diseases associated with chemical, biological, radiological, or nuclear threats.

They encompass a wide range of products, including biologic products like vaccines, blood products, and antibodies, as well as drugs such as antimicrobial or antiviral drugs, and devices like diagnostic tests and personal protective equipment. MC2 works to enhance national public health security and emergency preparedness through sound public policy and strong public-private partnerships. They collaborate with academic institutions, biotech and pharmaceutical companies, and other organizations committed to building an effective medical countermeasure enterprise.

To learn more about their mission and work or to get involved, visit the Medical Countermeasures Coalition online or contact them directly via email or phone